Autosomal Dominant Polycystic Kidney

Polycystic Kidney, Autosomal Dominant is a genetic condition that affects the kidneys. It causes many cysts, like small balloons, to grow in both kidneys. Over time, these cysts can enlarge and damage the kidneys, leading to kidney failure. It's inherited, meaning you can get it if a parent has it.

Condition

What people with Autosomal Dominant Polycystic Kidney report

Every report comes from a Lived member, sent anonymously.

Have you tried Tolvaptan for Autosomal Dominant Polycystic Kidney?

NameHow it went

About Autosomal Dominant Polycystic Kidney

What It Is

Autosomal dominant polycystic kidney disease (ADPKD) is an inherited condition in which many fluid-filled sacs, called cysts, form and slowly grow in both kidneys. Over many years the cysts enlarge the kidneys and crowd out the healthy tissue that filters the blood, so kidney function gradually declines. It is the most common inherited kidney disease and an important cause of kidney failure. The cysts begin forming early in life, but most people are diagnosed as adults, often between their late 20s and early 40s. High blood pressure is usually the first problem, and many people also have pain in the back or sides or notice blood in the urine. ADPKD affects other organs too: most people have cysts in the liver by middle age, and a smaller number develop a bulge in a blood vessel in the brain, called an aneurysm. The course varies widely. Some people keep good kidney function into old age, while others need dialysis or a transplant in middle age. ADPKD is different from autosomal recessive polycystic kidney disease, a rarer form that usually appears before or soon after birth, and from the simple kidney cysts many people develop with age, which are usually harmless.

Causes & Risk Factors

ADPKD is caused by a change (variant) in a single gene, most often PKD1 and less often PKD2. These genes make proteins that help kidney cells sense their surroundings and keep their growth in check. When the protein is faulty, cells lining the kidney's tiny tubes multiply and pour fluid inward, forming cysts that keep expanding. "Autosomal dominant" means one altered copy of the gene is enough to cause the disease, so it can pass from one affected parent to a child of either sex. Most people with ADPKD have an affected parent, but in roughly 10 to 25% of families the disease appears with no known family history, sometimes because the gene change arose for the first time. The gene determines who has ADPKD, but other factors influence how fast it progresses. PKD1 disease is usually more severe than PKD2 disease, with kidney failure arriving roughly 17 years earlier on average. High blood pressure, excess weight and a high-salt diet are associated with faster kidney growth or faster loss of function. These are things that can be managed; they do not mean a person caused their disease.

How It's Diagnosed

Diagnosis usually rests on kidney imaging combined with family history. An ultrasound shows the cysts, and when a parent or sibling has ADPKD, finding more than a small, age-specific number of cysts is enough to make the diagnosis. MRI picks up smaller cysts and is preferred for younger adults. Because cysts accumulate with age, a normal ultrasound in a child or young adult does not rule ADPKD out. Genetic testing is not needed for everyone. It is most useful when there is no family history, when the imaging looks unusual, when a young relative is being considered as a kidney donor, or when someone wants to explore options for having children. Testing an at-risk relative who feels well is a personal decision, since a diagnosis can affect future life or disability insurance. Either way, relatives at risk, including children, should have their blood pressure checked regularly, because high blood pressure can begin in childhood. Kidney function is tracked with the eGFR (estimated glomerular filtration rate), a blood test estimate of how much blood the kidneys filter each minute; a lower number means less filtering. In ADPKD the eGFR often stays normal for years while the kidneys keep enlarging, so kidney size is a better early guide. Measuring total kidney volume with MRI or CT and adjusting it for height and age places a person in the Mayo Imaging Classification, from class 1A to 1E. Classes 1C to 1E mean the kidneys are growing faster and predict earlier kidney failure, which helps decide who might benefit from treatment to slow the disease.

Treatment Options

There is no cure for ADPKD, but treatment can slow kidney damage, control complications and, for some people, delay kidney failure. Care is usually led by a kidney specialist (nephrologist). Blood pressure control is the foundation. Medicines that relax the blood vessels by blocking the angiotensin hormone system, angiotensin-converting enzyme (ACE) inhibitors such as lisinopril or angiotensin receptor blockers (ARBs), are the usual first choice. These medicines can harm a developing baby, so people who could become pregnant should discuss switching before trying to conceive and contact their care team promptly if they become pregnant while taking one. For most adults the goal is a top (systolic) number below 120. For people under 50 whose kidneys are enlarging quickly but still filter well, a lower target, below 110/75, may be recommended because tighter control slowed kidney growth in that group. Everyday habits matter too: limiting sodium to about 2 grams a day, keeping a healthy weight and drinking plenty of water, which also helps prevent the kidney stones that are more common in ADPKD. Tolvaptan (Jynarque, also available as a generic) is the one medicine approved to slow the disease itself. It blocks vasopressin, a hormone that tells the kidneys to hold on to water and that also drives cyst growth. It is meant for adults at risk of rapid progression, such as those in Mayo classes 1C to 1E or whose eGFR is falling quickly. In studies it slowed the yearly loss of kidney function by roughly one eGFR point per year, a partial slowing rather than a halt; it does not reverse damage and has not been shown to prevent kidney failure. The trade-offs are real: it causes large volumes of dilute urine, constant thirst and waking at night to urinate, and it can cause serious liver injury, so liver blood tests are required before starting, frequently in the first weeks, monthly for the first 18 months and every 3 months after that. Pain is treated according to its cause. Acetaminophen is generally preferred, while nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen are used sparingly or avoided because they can harm the kidneys. A single large, painful cyst can sometimes be drained and treated with a sclerosing agent (a substance that seals the cyst lining so it is less likely to refill), though fluid may return; surgery is reserved for severe cases. An infected cyst needs a longer course of antibiotics, often 4 to 6 weeks, than an ordinary urinary infection. If the kidneys fail, dialysis or a kidney transplant replaces their work. Screening for brain aneurysms with an MRI or CT scan of the blood vessels is not automatic. It is usually offered to people with a family history of aneurysm or brain bleeding and is otherwise decided individually, considering upcoming major surgery, high-risk jobs such as piloting, and personal preference.

What to Expect

ADPKD is lifelong and usually changes slowly. Many people feel well for decades, and the main early tasks are controlling blood pressure and keeping up with check-ups. About half of people with ADPKD need dialysis or a transplant by their early 60s, but that average hides a wide range: people with PKD2 disease or slower-growing kidneys may never reach kidney failure. Regular visits with a kidney specialist typically include blood pressure checks, blood and urine tests, and occasional imaging. As the kidneys and liver enlarge, some people feel fullness in the abdomen or long-lasting back and side discomfort, and chronic pain is common enough to be worth raising openly. Sudden pain from a bleeding cyst usually settles within one to two weeks with rest, fluids and pain control. Liver cysts tend to be more common and more severe in women, likely because estrogen encourages their growth. Most pregnancies in people with ADPKD go well, with live birth rates similar to the general population, but high blood pressure and pre-eclampsia (a pregnancy complication with high blood pressure and strain on organs such as the kidneys and liver) are more common, so pregnancy calls for closer monitoring. People planning a family may want genetic counseling; embryo testing during IVF (in vitro fertilization) can avoid passing on the gene. Because ADPKD runs in families, it often shapes conversations with parents, siblings and children, and support from the care team and patient groups can help.

When to Seek Help

Arrange a visit if a parent, sibling or child has ADPKD and you want to talk about screening, if your blood pressure is high, or if you are planning a pregnancy or considering donating a kidney to a relative. Contact your care team promptly for blood in the urine (pink, red or cola-colored), fever with flank or back pain, or new pain in the side that is severe or not settling. Also contact your care team about headaches that are severe, unlike your usual ones or persistent, rather than just treating them with over-the-counter medicine. Call 911 for a sudden, severe headache that reaches full intensity within seconds to a minute (a thunderclap headache), because it can signal a ruptured brain aneurysm.

Questions to Ask Your Doctor

  1. 1.Based on my kidney size, kidney function and family history, how quickly is my ADPKD likely to progress?
  2. 2.What blood pressure target makes sense for me, and should I be checking it at home?
  3. 3.Am I a candidate for tolvaptan, and how would we weigh its benefit against the side effects and liver monitoring?
  4. 4.Should I be screened for a brain aneurysm, given my family history and plans?
  5. 5.What should my children and other relatives know about testing and blood pressure checks?

Last reviewed • Oct 2026

Educational content, not medical advice.